NCT05959096View on ClinicalTrials.gov

A Study of LY3437943 in Healthy Participants With a High Body Mass Index

PHASE1CompletedINTERVENTIONAL

Enrollment

85

Participants

Timeline

Start Date

July 18, 2023

Primary Completion Date

July 25, 2024

Study Completion Date

July 25, 2024

Conditions

Healthy

Interventions

DRUG

LY3437943

Administered SC

DRUG

LY3437943

Administered IV

Trial Locations (1)

32117

Fortrea Clinical Research Unit, Daytona Beach

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY